Nippon Chemiphar CoTSE:4539 +1.38%59 Pretax Margin % is 0.09% as of Mar. 2026, which is 96% below its 10-year median of 2.29. GuruFocus rates TSE:4539 with a GF Score™ of 59/100 and a GF Value™ of 円1,705.64 (Fairly Valued). The stock has 9 warning signs investors should review. Among 961 Drug Manufacturers companies, Nippon Chemiphar Co ranks worse than 65.87% on this metric.
The historical rank and industry rank for Nippon Chemiphar Co's Pretax Margin % or its related term are showing as below:
TSE:4539'
s Pretax Margin % Range Over the Past 10 Years
Min: -0.66 Med: 2.29 Max: 7.98
Current: 0.67
TSE:4539's Pretax Margin % is ranked worse than 65.87% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs TSE:4539: 0.67
Nippon Chemiphar Co (TSE:4539) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Nippon Chemiphar Co Pretax Margin % Related Terms
Nippon Chemiphar Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Nippon Chemiphar Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Chemiphar Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Chemiphar Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Chemiphar Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Nippon Chemiphar Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Chemiphar Co (TSE:4539) has a Pretax Margin % of 0.09% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nippon Chemiphar Co and its competitors. This is 96% below median its historical median of 2.29. According to the industry distribution chart, Nippon Chemiphar Co ranks #633 out of 961 companies in the Drug Manufacturers industry, placing it in the top 65.9%.
Is Nippon Chemiphar Co's Pretax Margin % too high?
Nippon Chemiphar Co's current Pretax Margin % of 0.09% is 96% below median its 10-year median of 2.29. The Drug Manufacturers industry median Pretax Margin % is 7.28. Nippon Chemiphar Co's value of 0.09% is 98.8% below this industry median. Based on the distribution chart, Nippon Chemiphar Co ranks #633 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Nippon Chemiphar Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nippon Chemiphar Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Chemiphar Co ranks #633 out of 961 companies for Pretax Margin %. This places Nippon Chemiphar Co in the lower half of its industry. The industry median Pretax Margin % is 7.28. Nippon Chemiphar Co's value of 0.09% is 98.8% below this benchmark. While the company's 10-year median is 2.29 vs. the industry median of 7.28, Nippon Chemiphar Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Chemiphar Co's current Pretax Margin % of 0.09% is 98.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Nippon Chemiphar Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Chemiphar Co's current Pretax Margin % is 0.09%, which is 96% below median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Chemiphar Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Chemiphar Co (TSE:4539) is currently considered Fairly Valued. The stock's GF Value™ is 円1,705.64, compared to a current price of 円1,692.00 — trading 0.8% below its estimated fair value. The current Pretax Margin % is 0.09%, which is 96% below median its 10-year median of 2.29 and 98.8% below the Drug Manufacturers industry median of 7.28. Nippon Chemiphar Co's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Nippon Chemiphar Co (TSE:4539), the current Pretax Margin % is 0.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Chemiphar Co (TSE:4539) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Chemiphar Co stock appears to be undervalued.
The current stock price of 円1,692.00 is trading 0.8% below its estimated GF Value™ of 円1,705.64.
GuruFocus considers Nippon Chemiphar Co to be Fairly Valued.
Key valuation signals for TSE:4539:
Pretax Margin %: 0.09% (96% below median its 10-year median of 2.29)
GF Value™: 円1,705.64 vs. price of 円1,692.00 (0.8% below fair value)
Industry Position: 98.8% below the Drug Manufacturers median (#633 of 961)
No single metric tells the full story. See the TSE:4539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Chemiphar Co Ltd produces and sells medicines for medical use. The company also produces medical, health and cosmetics products. Nippon Chemiphar sterilizes medical instruments for hospitals and operates nursing home for elderly.
59GF Score
Get the complete analysis for TSE:4539
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4539 has been successfully added to your 
